Main Findings
There was a non-significant increase in the number of IUDs pandemic period compared to pre-pandemic period, 2.85/1000 births compared to 1.22/1000 births (p=0.10).
None of the patients tested positive for SARS-CoV-2 either during their admission, or during their antenatal course. This was during the early stages of pandemic when there was lack of access and strict case criteria for testing.
There was no significant difference in the age, BMI, ethnic category, or parity between cohorts. There was no significant difference in the rates of multiple pregnancy, gestational diabetes, pregnancy induced hypertension, pre-eclampsia, small for gestational age, and in-utero growth restriction.
There was no significant difference in white cell count (WCC), neutrophils, neutrophil: lymphocyte ratio, platelets, alanine transaminase (ALT), C-reactive protein (CRP), activated partial thromboplastin time (APTT), or prothrombin time (PT). There was a significant reduction in the mean lymphocyte count in 2020 compared to 2019 (p = 0.03).
Pregnancy outcomes were similar between the two years, with an average gestation at delivery of 33+0/40 in 2019, and 35+2/40 in 2020. The was no significant difference in the mode of delivery, estimated blood loss, or mean birth weight. Pregnancy outcomes are outlined in Table 3.